Back to ARK Investment Management LLC

RXRX
Showing 8 of 20 quarters

Position history for ARK Investment Management LLC's holdings in RECURSION PHARMACEUTICALS IN

ARK Investment Management LLC holds 40.2M shares of RXRX (RECURSION PHARMACEUTICALS IN), worth $123.5M as of 2026-Q1. The position was increased (+7.8% shares). RXRX represents 1.0% of ARK Investment Management LLC's portfolio.

Current Value

$123.5M

Current Shares

40.2M

Total Value Change

-$87.6M

Total Shares Change

+12.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
40.2M
+7.8%
$123.5M1.0%$3.54
46
2025-Q4
Increased
37.3M
+11.2%
$152.6M1.0%$4.11
53
2025-Q3
Increased
33.5M
+1.7%
$163.7M1.0%$4.91
43
2025-Q2
Decreased
33M
-5.3%
$166.9M1.2%$5.03
0
2025-Q1
Increased
34.8M
+7.6%
$184.2M1.8%$5.81
52
2024-Q4
Decreased
32.3M
-1.3%
$218.7M1.8%$6.77
0
2024-Q3
Increased
32.8M
+16.4%
$215.9M2.0%$6.98
56
2024-Q2
Increased
28.1M
+14.5%
$211.1M1.9%$7.50
55

Other major holders of RXRX: BAILLIE GIFFORD & CO

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used